Picard Medical (PMI) Debt to Equity (2025 - 2026)

Picard Medical posted quarterly Debt to Equity of -$1.49 for Q1 2026, down 203.6% on a QoQ basis from $1.44 in Q4 2025.

Picard Medical (PMI) has 2 years of Debt to Equity data on file, last reported at -$1.49 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity changed N/A year-over-year to -$1.49; the trailing twelve-month figure through Mar 2026 stood at -$1.49 (changed N/A YoY), and the FY2025 full-year result was $1.44, changed N/A from the prior year.
  • Debt to Equity for Q1 2026 stood at -$1.49, down from $1.44 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.44 in Q4 2025 and bottomed at -$1.49 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00 -1.49

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.49
Dec 31, 2025 1.44